Bioxytran Stock Buy Hold or Sell Recommendation
| BIXT Stock | USD 0.13 0.02 13.33% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Bioxytran is 'Strong Sell'. Macroaxis provides Bioxytran buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding BIXT positions. The advice algorithm takes into account all of Bioxytran's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Bioxytran's buy or sell advice are summarized below:
Real Value 0.11 | Hype Value 0.13 | Market Value 0.13 | Naive Value 0.13 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Bioxytran given historical horizon and risk tolerance towards Bioxytran. When Macroaxis issues a 'buy' or 'sell' recommendation for Bioxytran, the advice is generated through an automated system that utilizes algorithms and statistical models.
Bioxytran |
Execute Bioxytran Buy or Sell Advice
The Bioxytran recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Bioxytran. Macroaxis does not own or have any residual interests in Bioxytran or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Bioxytran's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Insignificant | Details | |
Volatility | Out of control | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Very High | Details | |
Economic Sensitivity | Hyperactively responds to market trends | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Bioxytran Trading Alerts and Improvement Suggestions
| Bioxytran had very high historical volatility over the last 90 days | |
| Bioxytran has some characteristics of a very speculative penny stock | |
| Bioxytran has a very high chance of going through financial distress in the upcoming years | |
| The company currently holds 2.17 M in liabilities. Bioxytran has a current ratio of 0.09, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Bioxytran until it has trouble settling it off, either with new capital or with free cash flow. So, Bioxytran's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Bioxytran sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Bioxytran to invest in growth at high rates of return. When we think about Bioxytran's use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (4.04 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Bioxytran currently holds about 500.68 K in cash with (839.44 K) of positive cash flow from operations. | |
| Roughly 66.0% of the company shares are held by company insiders |
Bioxytran Returns Distribution Density
The distribution of Bioxytran's historical returns is an attempt to chart the uncertainty of Bioxytran's future price movements. The chart of the probability distribution of Bioxytran daily returns describes the distribution of returns around its average expected value. We use Bioxytran price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Bioxytran returns is essential to provide solid investment advice for Bioxytran.
| Mean Return | 0.64 | Value At Risk | -9.09 | Potential Upside | 10.00 | Standard Deviation | 7.81 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Bioxytran historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Bioxytran Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Bioxytran or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Bioxytran's price will be affected by overall otc stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Bioxytran otc's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | 0.41 | |
β | Beta against NYSE Composite | 2.63 | |
σ | Overall volatility | 7.86 | |
Ir | Information ratio | 0.07 |
Bioxytran Volatility Alert
Bioxytran is showing large volatility of returns over the selected time horizon. Bioxytran is a potential penny stock. Although Bioxytran may be in fact a good instrument to invest, many penny otc stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Bioxytran. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Bioxytran instrument if you perfectly time your entry and exit. However, remember that penny otcs that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Bioxytran Fundamentals Vs Peers
Comparing Bioxytran's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Bioxytran's direct or indirect competition across all of the common fundamentals between Bioxytran and the related equities. This way, we can detect undervalued stocks with similar characteristics as Bioxytran or determine the otc stocks which would be an excellent addition to an existing portfolio. Peer analysis of Bioxytran's fundamental indicators could also be used in its relative valuation, which is a method of valuing Bioxytran by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Bioxytran to competition |
| Fundamentals | Bioxytran | Peer Average |
| Return On Asset | -7.04 | -0.14 |
| Current Valuation | 19.06 M | 16.62 B |
| Shares Outstanding | 144.64 M | 571.82 M |
| Shares Owned By Insiders | 65.60 % | 10.09 % |
| Price To Sales | 532.56 X | 11.42 X |
| EBITDA | (3.59 M) | 3.9 B |
| Net Income | (4.04 M) | 570.98 M |
| Cash And Equivalents | 500.68 K | 2.7 B |
| Total Debt | 2.17 M | 5.32 B |
| Current Ratio | 0.09 X | 2.16 X |
| Book Value Per Share | (0.01) X | 1.93 K |
| Cash Flow From Operations | (839.44 K) | 971.22 M |
| Earnings Per Share | (0.03) X | 3.12 X |
| Target Price | 2.71 | |
| Number Of Employees | 2 | 18.84 K |
| Beta | -0.43 | -0.15 |
| Market Capitalization | 17.21 M | 19.03 B |
| Total Asset | 370.94 K | 29.47 B |
| Retained Earnings | (11.22 M) | 9.33 B |
| Working Capital | (3.37 M) | 1.48 B |
| Z Score | -80.36 | 8.72 |
| Net Asset | 370.94 K |
Note: Acquisition by Alan Hoberman of 77721 shares of Bioxytran subject to Rule 16b-3 [view details]
Bioxytran Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Bioxytran . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Bioxytran Buy or Sell Advice
When is the right time to buy or sell Bioxytran? Buying financial instruments such as Bioxytran OTC Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Bioxytran in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Artificial Intelligence Thematic Idea Now
Artificial Intelligence
Technology companies, funds, and ETFs across multiple industries that are involved in research or development in the field of reasoning, learning, natural language processing and perception as well as its application to science and commerce. This theme may also include entities involved in cybernetics and cognitive brain simulation field. The Artificial Intelligence theme has 41 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Artificial Intelligence Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Bioxytran Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Complementary Tools for Bioxytran OTC Stock analysis
When running Bioxytran's price analysis, check to measure Bioxytran's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioxytran is operating at the current time. Most of Bioxytran's value examination focuses on studying past and present price action to predict the probability of Bioxytran's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bioxytran's price. Additionally, you may evaluate how the addition of Bioxytran to your portfolios can decrease your overall portfolio volatility.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |